ArticleEuropean geriatric medicine2026
Biomarker-defined congestion profiles in very old adults with acute heart failure: beyond ejection fraction classification.
Article in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Novel blood biomarkers for heart failure mortality: mechanistic pathways, aging biology, and risk stratification.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCongestion is the main driver of worsening acute heart failure, yet its manifestation in very old adults and its relationship with prognosis remains incompletely understood. Traditional classification based on left ventricular ejection fraction (LVEF) may not adequately capture the biological heterogeneity of congestion in this population. We aimed to characterize patient subgroups defined by BNP and CA125 constellations, to characterize their clinical and echocardiographic features, and to evaluate their prognostic implications. As a secondary objective, we explored their relationship with conventional LVEF categories.
methodsWe conducted a retrospective cohort study including 830 consecutive patients hospitalized with acute heart failure. Congestion was assessed using clinical signs, echocardiography, biomarkers (BNP and CA125), and point-of-care ultrasound. Outcomes included heart failure rehospitalization and all-cause mortality over a median follow-up of 310 days (IQR 62-543). Multivariable Cox regression models were used.
resultsThe median age was 87 years, and 65.6% were women. Four patient subgroups were defined by BNP and CA125 constellations, showing distinct clinical and echocardiographic profiles. Mortality increased progressively across phenotypes, with combined elevation of BNP and CA125 independently associated with higher risk of death (HR 1.48; p = 0.008). Isolated CA125 elevation was associated with increased rehospitalization risk (HR 1.45; p = 0.031). In contrast, LVEF categories showed limited prognostic discrimination.
conclusionsIn very old adults hospitalized with acute heart failure, combined elevation of BNP and CA125 was independently associated with increased mortality, while isolated CA125 elevation was associated with higher rehospitalization risk. LVEF was not independently associated with either outcome. These findings suggest that integrating BNP and CA125 may complement conventional LVEF classification for risk stratification in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.